An innovative cardiovascular start-up, HDAX Therapeutics, is the latest company to win $250,000 in funding following another year of the Ted Rogers Centre for Heart Research’s Entrepreneurship for Cardiovascular Health Opportunities (ECHO) program. The ECHO program...
By the Numbers
0 – Cures for heart failure
1st – Most rapidly rising cardiovascular disease in Canada
2.1 – Average survival rate, in years
10 – Average length of stay in hospital, in days
25 – Percent, the projected growth of heart failure prevalence in the next 20 years.
26 – Days of hospital resources by average patient in 1st year of treatment
60,000 – Canadians diagnosed each year
1 million – Canadians have heart failure
1.4 million – Hospital stays each year
$3 billion – Its toll on the Canadian health-care system